相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS)
Cindy E. Neunert et al.
BLOOD (2013)
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group
Francesco Rodeghiero et al.
BLOOD (2013)
Efficacy of eltrombopag in management of bleeding symptoms associated with chronic immune thrombocytopenia
Michael D. Tarantino et al.
BLOOD COAGULATION & FIBRINOLYSIS (2013)
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
David J. Kuter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQL™ 4.0 Generic Core Scales: a study on behalf of the pays de Loire pediatric hematology network
Marion Strullu et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2013)
Patterns of Inpatient Care for Newly Diagnosed Immune Thrombocytopenia in US Children's Hospitals
Courtney Kime et al.
PEDIATRICS (2013)
Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort
Steen Rosthoj et al.
ACTA PAEDIATRICA (2012)
Immune thrombocytopenia: Getting back to basics
Donald M. Arnold
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care
David J. Kuter et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia
Patrick F. Fogarty et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia (CME)
Kathryn E. Webert et al.
TRANSFUSION (2012)
Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group
Thomas Kuehne et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial
Yukari Shirasugi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia
Tadeusz Robak et al.
HEMATOLOGY (2010)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
S. Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Evaluating Bleeding Severity in Children with newly Diagnosed Immune Thrombocytopenia: A Pilot Study
J. Pansy et al.
KLINISCHE PADIATRIE (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study
Lidwine B. Mokkink et al.
QUALITY OF LIFE RESEARCH (2010)
Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP
James B. Bussel et al.
BLOOD (2009)
Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives
Jacqueline A. Guidry et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Efficacy and safety of Privigen®, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura
T. Robak et al.
HEMATOLOGY (2009)
Faster platelet recovery by high-dose dexamethasone compared with standard-dose prednisolone in adult immune thrombocytopenia: a prospective randomized trial
W. Praituan et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
James B. Bussel et al.
LANCET (2009)
Relationships Among Bleeding Severity, Health-Related Quality of Life, and Platelet Count in Children With Immune Thrombocytopenic Purpura
Cindy E. Neunert et al.
PEDIATRIC BLOOD & CANCER (2009)
Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura
Robert McMillan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Serious adverse events in academic critical care research
Deborah Cook et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:: a double-blind randomised controlled trial
David J. Kuter et al.
LANCET (2008)
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP
Lemke K. Page et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience
Maria Gabriella Mazzucconi et al.
BLOOD (2007)
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura
CM Bennett et al.
BLOOD (2006)
Platelet count, previous infection and FCGR2B genotype predict development of chronic disease in newly diagnosed idiopathic thrombocytopenia in childhood:: results of a prospective study
M Bruin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
New developments in idiopathic thrombocytopenic purpura (ITP):: Cooperative, prospective studies by the Intercontinental Childhood ITP Study Group
P Imbach et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)
CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment
A Trotti et al.
SEMINARS IN RADIATION ONCOLOGY (2003)
Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies
NM Heddle et al.
TRANSFUSION (2003)
Initial management of immune thrombocytopenic purpura in adults: A randomized controlled trial comparing intermittent anti-D with routine care
JN George et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura
GR Buchanan et al.
JOURNAL OF PEDIATRICS (2002)
Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura:: a randomised, multicentre trial
B Godeau et al.
LANCET (2002)
Morbidity and mortality in adults with idiopathic thrombocytopenic purpura
JEA Portielje et al.
BLOOD (2001)
The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts
YC Cohen et al.
ARCHIVES OF INTERNAL MEDICINE (2000)